Dibsan 1mg/500mg/15mg Tablet SR
Marketer
Tuttsan Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dibsan 1mg/500mg/15mg Tablet SR
GlycoBalance SR 1mg/500mg/15mg tablets are a combined formulation designed to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. GlycoBalance SR should be administered precisely as prescribed by your physician, taken with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol, or skipped meals increases the risk of hypoglycemia; regular blood glucose monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Renal function testing will be conducted before treatment commences. Limit alcohol consumption while on this medication, as this can exacerbate side effects.
Primary Ingredients of Dibsan 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Dibsan 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Dibsan 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Dibsan 1mg/500mg/15mg Extended-Release tablet with food.
Common Side effects of Dibsan 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dibsan 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Dibsan 1mg/500mg/15mg Extended-Release tablet with food.
How Dibsan 1mg/500mg/15mg Tablet SR works:
Dibsan SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual therapies prove insufficient. Glimepiride (a sulfonylurea) stimulates pancreatic insulin release, reducing blood glucose levels. Metformin (a biguanide) acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone (a thiazolidinedione) further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Dibsan 1mg/500mg/15mg SR tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dibsan 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Dibsan 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dibsan 1mg/500mg/15mg SR tablets, potentially requiring dosage modification. Consult your physician for guidance. Dibsan 1mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Dibsan 1mg/500mg/15mg SR tablets. Dosage modification may be necessary. A physician's consultation is advised. Dibsan 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Dibsan 1mg/500mg/15mg Tablet SR :
Should you forget to take a Dibsan 1mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dibsan 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently